Storing Lyophilized Research Peptides: Temperature, Moisture and Working Stocks

A lyophilized peptide arrives as a white to off-white cake in a sealed vial, and the temptation is to treat it as inert. It is not. Lyophilization removes most of the water that would drive hydrolysis in solution, but it does not remove the chemical pathways that degrade a peptide. Deamidation of asparagine and glutamine, oxidation of methionine and cysteine, isomerization, and aggregation all proceed in the solid state, only more slowly. Storage conditions decide how slowly, and what a laboratory does in the first ten minutes after opening the vial often matters more than the year that follows.

What stability actually measures

Stability is not a single number. A stability study asks whether a defined set of attributes stays inside a specification over time, under defined conditions, in a defined container. For a research peptide those attributes are usually identity by mass spectrometry, purity by RP-HPLC, water content, appearance, and where relevant counter-ion content and endotoxin. A batch can stay chemically intact and still fail on water content after a week in a humid drawer, which is why a purity figure alone never describes storage behaviour.

This is also why a supplier's storage instruction and a laboratory's own stability data answer different questions. The supplier states the condition under which the material was released, packed and shipped. The laboratory has to demonstrate that the material still meets specification at the point of use, in its own buffer, at its own concentration, in its own tubes. Both statements can be true at once and neither substitutes for the other.

Temperature: -20 °C, -80 °C and the cost of a freezer that cycles

Desiccated lyophilized peptides are conventionally held at -20 °C for long-term storage, with -80 °C used for material known to be sensitive or for working stocks in solution. The nominal set point matters less than its stability. A freezer that swings several degrees on every defrost cycle, or a frost-free unit that briefly runs a heating element, exposes the vial to repeated small excursions. Those excursions are cumulative, and they are invisible on the label.

Three practical consequences follow. Store vials in the dark inside a secondary sealed container, because light drives oxidation of aromatic and sulfur-containing residues. Keep peptides off the door shelf and away from the front edge of the compartment, where temperature varies most. And keep the vial sealed until it has equilibrated to room temperature: opening a cold vial in a warm room condenses water directly onto the powder, and that single step is the most common way a good batch is lost.

Moisture is the variable you cannot see

Water content is measured by Karl Fischer titration and reported on the certificate of analysis next to the purity figure. It is the attribute most affected by handling and least visible on inspection. A cake that looks unchanged can take up enough atmospheric moisture to accelerate hydrolysis, promote aggregation on reconstitution, and make weighing inaccurate through clumping and static.

The desiccant in the shipping pouch is doing real work, and it is spent the moment the pouch is opened. A vial returned to a drawer without desiccant is no longer under the condition described on its certificate. Where a batch will be used across months, divide it into single-use portions under dry conditions rather than opening the same vial repeatedly, and let the balance and the powder reach the same temperature before weighing so that condensation does not form on the material itself.

Reconstitution: solvent, pH and the surface of the tube

Most research peptides dissolve readily in water or in a buffer near neutral pH. Hydrophobic sequences may need a small proportion of acetonitrile, DMSO, or a dilute acid or base to enter solution, added stepwise with mixing rather than all at once. The solvent is part of the experiment, not an inert carrier: pH sets the charge state and therefore solubility and aggregation propensity, and a peptide that is entirely stable as a powder can associate within hours in the wrong buffer.

Adsorption to plastic is a real and often overlooked loss mechanism at low concentrations, particularly for hydrophobic and positively charged sequences. Low-binding tubes reduce it. Where the concentration is low enough that surface loss becomes a meaningful fraction of the total, a carrier or a defined buffer composition is worth validating before the experiment rather than after a disappointing recovery.

Freeze-thaw, aliquots and the working stock

Each freeze-thaw cycle is not a neutral event. As ice forms, the peptide is concentrated in the remaining liquid phase, and that transient concentration is what drives aggregation and surface-induced denaturation. The damage scales with the number of cycles and with how slowly the sample is frozen and thawed, which is why solution stocks should be handled in a way that keeps the cycle count low and recorded.

• Aliquot the reconstituted solution on the day it is prepared, before the first freeze, rather than freezing the whole vial and re-freezing what is left.
• Size each aliquot to one use. A partly used aliquot should be discarded, not returned to the freezer.
• Freeze solution stocks at -80 °C rather than -20 °C, and thaw on ice or at 4 °C. A warm water bath trades speed for aggregation.
• Write the cycle count on the tube. A stock without a cycle count cannot be defended in a methods section or transferred to another laboratory.
• Avoid repeated warming of the same tube for weighing or pipetting; bring out one aliquot and leave the rest cold.

Designing a stability protocol you can defend

A stability protocol for an in-house working stock does not need to be elaborate, but it does need to exist before the experiment. State the conditions — temperature, container, concentration, buffer — the time points, the assays, and the acceptance criteria in advance. Then measure the same attributes at every point, so that the trend rather than a single favourable result becomes the finding.

Time zero should be a measured result, not an assumption inherited from the supplier's certificate. Where the data will support a publication, a method transfer, or an audit of an incoming-material record, keep the raw chromatograms and spectra rather than only the summary percentages; the underlying traces are what allow a reviewer to see whether a small new peak is degradation or an injection artefact. Laboratories that need an independent read on a specific batch can commission analytical testing rather than relying on the release data alone.

Four questions are worth asking before a storage protocol is fixed, because each one changes an assumption the protocol depends on. First, what storage condition is stated on the certificate of analysis for this specific batch. Second, what water content was measured and by which method. Third, whether the consignment travelled at ambient or controlled temperature, since the material's history before it reached the laboratory is part of its condition. Fourth, what counter-ion form the peptide is in, because salt form affects hygroscopicity, solubility and the weighed quantity that corresponds to a given amount of peptide.

Answers to the first three should come with the release documentation; the fourth is usually a specification question. Materials in the research peptide catalog are listed with their vial format and storage condition, and the FAQ covers documentation and testing scope. If a project needs a specification that is not listed — a different salt form, a defined buffer, or additional testing — the inquiry form is the right entry point, and it helps to include the intended storage condition and the timeframe over which the material will be used.

None of this makes a peptide indestructible. It makes the handling reproducible, which is the only property that matters when a result has to be repeated by someone else. All peptide products discussed here are supplied for research use only. They are not for human or veterinary use, and not for therapeutic, diagnostic, cosmetic or injection application.